Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2005Breast Cancer ResearchOpen Access

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

View Full Paper
Ask AI
Bookmark
Share

Authors

YPYudi PawitanUniversity College DublinJBJudith BjöhleKarolinska InstitutetLALukas C. AmlerPCR Oncology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pawitan et al. (2005) studied this question.

synapsesocial.com/papers/6a11d41ba50709dd2cdcdb50https://doi.org/10.1186/bcr1325
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Correlation test to assess low-level processing of high-density oligonucleotide microarray data2005 · 51 citations
  2. 2A Randomized Trial of Letrozole in Postmenopausal Women After Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer2004 · 315 citations
  3. 3A Gene-Expression Signature as a Predictor of Survival in Breast Cancer2002 · 6,565 citations
  4. 4Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer2003 · 1,307 citations